Mrs Taylor Elise Sartin, GCNS-BC | |
12445 S 18th Cir, Jenks, OK 74037-3663 | |
(405) 590-4546 | |
Not Available |
Full Name | Mrs Taylor Elise Sartin |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Gerontology |
Location | 12445 S 18th Cir, Jenks, Oklahoma |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962657775 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SG0600X | Clinical Nurse Specialist - Gerontology | 81421 (Oklahoma) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Taylor Elise Sartin, GCNS-BC 12445 S 18th Cir, Jenks, OK 74037-3663 Ph: (405) 590-4546 | Mrs Taylor Elise Sartin, GCNS-BC 12445 S 18th Cir, Jenks, OK 74037-3663 Ph: (405) 590-4546 |
News Archive
GenoMed, Inc. a Next Generation Disease Management company that uses its expertise in genomics to improve clinical outcomes in as many species as possible, announced today that two non-profit groups which care for wild birds with West Nile virus encephalitis, including American bald eagles, will be using the Company's patent-pending treatment this season.
Synosia Therapeutics today announced the first clinical study results showing that SYN-118 provides clinically meaningful benefits to Parkinson's patients, has a good safety profile and is well tolerated. Results from an open-label, proof-of-mechanism study of SYN-118 (CL02) were presented at the World Parkinson Congress in Glasgow, Scotland.
Charles H. Hennekens, M.D., DrPH, the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Medicine at Florida Atlantic University, has published the results of A Randomized Trial of Aspirin at Clinically Relevant Doses and Nitric Oxide Formation in Humans in the current issue of the Journal of Cardiovascular Pharmacology and Therapeutics.
Morgan Advanced Materials, widely acknowledged as a global leader in ceramics and other advanced materials, has announced that it now has the capability to design and manufacture components for use in high intensity focused ultrasound (HIFU) technologies, particularly in medical applications.
› Verified 7 days ago